214 related articles for article (PubMed ID: 28053072)
1. The Promise of New Technologies to Reduce, Refine, or Replace Animal Use while Reducing Risks of Drug Induced Liver Injury in Pharmaceutical Development.
Sistare FD; Mattes WB; LeCluyse EL
ILAR J; 2016 Dec; 57(2):186-211. PubMed ID: 28053072
[TBL] [Abstract][Full Text] [Related]
2. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
[TBL] [Abstract][Full Text] [Related]
3. Development and Application of a Transcriptomic Signature of Bioactivation in an Advanced In Vitro Liver Model to Reduce Drug-induced Liver Injury Risk Early in the Pharmaceutical Pipeline.
Kang W; Podtelezhnikov AA; Tanis KQ; Pacchione S; Su M; Bleicher KB; Wang Z; Laws GM; Griffiths TG; Kuhls MC; Chen Q; Knemeyer I; Marsh DJ; Mitra K; Lebron J; Sistare FD
Toxicol Sci; 2020 Sep; 177(1):121-139. PubMed ID: 32559289
[TBL] [Abstract][Full Text] [Related]
4. Current limitations and future opportunities for prediction of DILI from in vitro.
Funk C; Roth A
Arch Toxicol; 2017 Jan; 91(1):131-142. PubMed ID: 27766365
[TBL] [Abstract][Full Text] [Related]
5. Minimizing DILI risk in drug discovery - A screening tool for drug candidates.
Schadt S; Simon S; Kustermann S; Boess F; McGinnis C; Brink A; Lieven R; Fowler S; Youdim K; Ullah M; Marschmann M; Zihlmann C; Siegrist YM; Cascais AC; Di Lenarda E; Durr E; Schaub N; Ang X; Starke V; Singer T; Alvarez-Sanchez R; Roth AB; Schuler F; Funk C
Toxicol In Vitro; 2015 Dec; 30(1 Pt B):429-37. PubMed ID: 26407524
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced liver injury and drug development: industry perspective.
Regev A
Semin Liver Dis; 2014 May; 34(2):227-39. PubMed ID: 24879986
[TBL] [Abstract][Full Text] [Related]
7. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
Amacher DE
Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
[TBL] [Abstract][Full Text] [Related]
8. Advancing Predictive Hepatotoxicity at the Intersection of Experimental, in Silico, and Artificial Intelligence Technologies.
Fraser K; Bruckner DM; Dordick JS
Chem Res Toxicol; 2018 Jun; 31(6):412-430. PubMed ID: 29722533
[TBL] [Abstract][Full Text] [Related]
9. Development of novel tools for the in vitro investigation of drug-induced liver injury.
Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM
Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718
[TBL] [Abstract][Full Text] [Related]
10. Moving beyond Binary Predictions of Human Drug-Induced Liver Injury (DILI) toward Contrasting Relative Risk Potential.
Aleo MD; Shah F; Allen S; Barton HA; Costales C; Lazzaro S; Leung L; Nilson A; Obach RS; Rodrigues AD; Will Y
Chem Res Toxicol; 2020 Jan; 33(1):223-238. PubMed ID: 31532188
[TBL] [Abstract][Full Text] [Related]
11. Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.
Aleo MD; Luo Y; Swiss R; Bonin PD; Potter DM; Will Y
Hepatology; 2014 Sep; 60(3):1015-22. PubMed ID: 24799086
[TBL] [Abstract][Full Text] [Related]
12. Toward predictive models for drug-induced liver injury in humans: are we there yet?
Chen M; Bisgin H; Tong L; Hong H; Fang H; Borlak J; Tong W
Biomark Med; 2014; 8(2):201-13. PubMed ID: 24521015
[TBL] [Abstract][Full Text] [Related]
13. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
[TBL] [Abstract][Full Text] [Related]
14. A high content screening assay to predict human drug-induced liver injury during drug discovery.
Persson M; Løye AF; Mow T; Hornberg JJ
J Pharmacol Toxicol Methods; 2013; 68(3):302-13. PubMed ID: 23933113
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-based integrated assay systems for the prediction of drug-induced liver injury.
Kawaguchi M; Nukaga T; Sekine S; Takemura A; Susukida T; Oeda S; Kodama A; Hirota M; Kouzuki H; Ito K
Toxicol Appl Pharmacol; 2020 May; 394():114958. PubMed ID: 32198022
[TBL] [Abstract][Full Text] [Related]
16. Metabolomic approaches in the discovery of potential urinary biomarkers of drug-induced liver injury (DILI).
Araújo AM; Carvalho M; Carvalho F; Bastos ML; Guedes de Pinho P
Crit Rev Toxicol; 2017 Sep; 47(8):633-649. PubMed ID: 28436314
[TBL] [Abstract][Full Text] [Related]
17. [Establishment of animal models of drug-induced liver injury and analysis of possible mechanisms].
Oda S; Yokoi T
Yakugaku Zasshi; 2015; 135(4):579-88. PubMed ID: 25832838
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Drug-Induced Liver Injury Prediction: Criteria Optimization of Efflux Transporter IC50 and Physicochemical Properties.
Yucha RW; He K; Shi Q; Cai L; Nakashita Y; Xia CQ; Liao M
Toxicol Sci; 2017 Jun; 157(2):487-499. PubMed ID: 28369588
[TBL] [Abstract][Full Text] [Related]
19. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
Liss G; Rattan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
[TBL] [Abstract][Full Text] [Related]
20. Models of Idiosyncratic Drug-Induced Liver Injury.
Yokoi T; Oda S
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():247-268. PubMed ID: 32976738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
